Impact of the TRPV2 Inhibitor on Advanced Heart Failure in Patients with Muscular Dystrophy: Exploratory Study of Biomarkers Related to the Efficacy of Tranilast

Cardiomyopathy is the leading cause of death in patients with muscular dystrophy (MD). Tranilast, a widely used anti-allergic drug, has displayed inhibitory activity against the transient receptor potential cation channel subfamily V member 2 and improved cardiac function in MD patients. To identify...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Chisato, Oishi, Mariko, Iwata, Yuko, Maekawa, Keiko, Matsumura, Tsuyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917168/
https://www.ncbi.nlm.nih.gov/pubmed/36768491
http://dx.doi.org/10.3390/ijms24032167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917168/
https://www.ncbi.nlm.nih.gov/pubmed/36768491
http://dx.doi.org/10.3390/ijms24032167

Ejemplares similares